These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 38508666)

  • 21. Outcomes of surgical resection after neoadjuvant chemoimmunotherapy in locally advanced stage IIIA non-small-cell lung cancer.
    Romero Román A; Campo-Cañaveral de la Cruz JL; Macía I; Escobar Campuzano I; Figueroa Almánzar S; Delgado Roel M; Gálvez Muñoz C; García Fontán EM; Muguruza Trueba I; Romero Vielva L; Cano Garcia JR; Martínez Téllez E; Partida González C; Jiménez López MF; Jiménez Maestre U; Mongil Poce R; Sánchez Lorente D; Álvarez Kindelán A; Provencio Pulla M
    Eur J Cardiothorac Surg; 2021 Jul; 60(1):81-88. PubMed ID: 33661301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical approach to locally advanced non-small cell lung cancer.
    Donington JS; Pass HI
    Cancer J; 2013; 19(3):217-21. PubMed ID: 23708068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is VATS lobectomy standard of care for operable non-small cell lung cancer?
    Vannucci F; Gonzalez-Rivas D
    Lung Cancer; 2016 Oct; 100():114-119. PubMed ID: 27597290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of minimally invasive approaches for stage I non-small cell lung cancer: A surgeon's point of view].
    Thomas PA
    Cancer Radiother; 2015 Oct; 19(6-7):365-70. PubMed ID: 26344441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Surgery in Management of Locally Advanced Non-Small Cell Lung Cancer.
    Bryan DS; Donington JS
    Curr Treat Options Oncol; 2019 Mar; 20(4):27. PubMed ID: 30874964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy.
    Mitsos S; Petko M; Patrini D; Hayward M; Scarci M; Lawrence D; Panagiotopoulos N
    Indian J Cancer; 2017; 54(1):73-81. PubMed ID: 29199668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current readings: sublobar resection for non-small-cell lung cancer.
    Donington JS
    Semin Thorac Cardiovasc Surg; 2013; 25(1):22-9. PubMed ID: 23800526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could less be more?-A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection.
    Cao C; Chandrakumar D; Gupta S; Yan TD; Tian DH
    Lung Cancer; 2015 Aug; 89(2):121-32. PubMed ID: 26033208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
    Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oncologic efficacy of extended resections for lung cancer.
    Etienne H; Kalt F; Park S; Opitz I
    J Surg Oncol; 2023 Feb; 127(2):296-307. PubMed ID: 36630100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of centrally located non-small-cell carcinoma.
    Backhus LM; Wood DE
    Oncology (Williston Park); 2014 Mar; 28(3):215-21. PubMed ID: 24855729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally invasive resection of early lung cancers.
    Cheng AM; Wood DE
    Oncology (Williston Park); 2015 Mar; 29(3):160-6. PubMed ID: 25772453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical aspects in the treatment of lung cancer.
    Bilfinger TV
    Curr Opin Pulm Med; 2004 Jul; 10(4):261-5. PubMed ID: 15220749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of cutting-edge surgery in stage IIIA-N2 nonsmall cell lung cancer.
    Rocco G
    Curr Opin Oncol; 2009 Mar; 21(2):105-9. PubMed ID: 19532010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Issues for Operable Early-Stage Non-Small-Cell Lung Cancer.
    Donington J; Schumacher L; Yanagawa J
    J Clin Oncol; 2022 Feb; 40(6):530-538. PubMed ID: 34985938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.
    De Craene S; Surmont V; van Meerbeeck JP
    Curr Opin Oncol; 2010 Mar; 22(2):102-11. PubMed ID: 20180283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.